01 mar: Sjælsø Gruppen A/S' årsregnskabsmeddelelse for 2010
01 mar: FormueEvolution I A/S - Insiderer handel
01-03-2011 09:00:00

Cerner Fulfills CE Marking Requirements for Medical Device Connectivity Solution

Cerner CareAware iBus Solution Approved to be Offered in the European Union

KANSAS CITY, Mo., 2011-03-01 09:00 CET (GLOBE NEWSWIRE) --Cerner Corporation today announced that the CareAware iBus has received CE

Marking certification from BSI on the basis of examination under Council

Directive 93/42/EEC Annex II Section 3.2.

The Cerner CareAware iBus solution connects important medical device

information about patient health from disparate systems to the patient's

electronic health record (EHR). This solution will be immediately available to

healthcare organizations in the EU allowing them to access medical information

from medical devices and EHRs to make informed care decisions.

"As a global leader in the development of device connectivity and workflow

solutions, we are excited to extend the offering of our CareAware iBus solution

into the European market," said Tom Herzog, Cerner vice president for IT and

healthcare devices. "Connecting medical devices to the patient's EHR supports

healthcare interoperability, enabling patients and caregivers to access the

right information at the right time."

The Cerner CareAware iBus solution works to improve clinician workflow and

patient safety by:

-- Reducing time spent manually transcribing device data into the EHR,

allowing clinicians to spend more time on direct patient care;

-- Decreasing the chance of medication errors by virtually eliminating manual

data entry errors and increasing the accuracy of data;

-- Providing the ability to automatically perform calculations on medical

device data, including trending capabilities for various sources of

information like heart rate and blood pressure;

-- Reducing interface implementation and maintenance costs through efficient

management of medical device deployment; and

-- Improving monitoring abilities of device performance, connectivity status

and device utilization.

The Cerner CareAware iBus solution provides additional functionality and

workflow benefits. Plug-and-play capabilities for connecting medical devices to

any EHR system allow medical devices to connect to the Cerner CareAware iBus

much like a USB port that quickly and easily connects peripheral devices to a

computer. Once a device is connected, it is immediately recognized and can

begin transmitting patient data to the EHR. The solution also allows waveform

data to be transmitted directly into the EHR. Clinicians may then analyze the

patient's device data in the context of other clinically relevant data for a

specific time period, enabling them to make the best informed care decisions

with all relevant information easily accessible from multiple medical devices.

About Cerner

Cerner is transforming healthcare by eliminating error, variance and waste for

healthcare providers and consumers around the world. Cerner® solutions optimize

processes for healthcare organizations ranging in size from single-doctor

practices, to health systems, to entire countries, for the pharmaceutical and

medical device industries, employer health and wellness services industry and

for the healthcare commerce system. These solutions are licensed by

approximately 9,000 facilities around the world, including more than 2,600

hospitals; 3,500 physician practices covering more than 30,000 physicians; 500

ambulatory facilities, such as laboratories, ambulatory centers, cardiac

facilities, radiology clinics and surgery centers; 800 home health facilities;

and 1,600 retail pharmacies. The trademarks, service marks and logos

(collectively, the "Marks") set forth herein are owned by Cerner Corporation

and/or its subsidiaries in the United States and certain other countries

throughout the world. Nasdaq:CERN. For more information about Cerner, please

visit www.cerner.com, Twitter, Facebook, and YouTube .

CONTACT: Cerner Media Contact:

Kelly Johnson

+1-816-777-8466

kelly.johnson@cerner.com

Cerner Investors Contact:

Allan Kells

+1-816-201-2445

akells@cerner.com

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
18 dec
VELO
Gennemgang og analyse af Veloxis' søgsmålJeg har brugt min aften på at "hygge" mig med Veloxis netop..
65
20 dec
 
Det er meget velbeskrevet i talrige bøger og artikler, at tilstandene i store dele af verden udenfor..
42
14 dec
GEN
Genmab kom sent fredag med en fondbørsmeddelse om en milestone på $3 milloner vedrørende deres DuoBo..
30
18 dec
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
29
18 dec
GEN
Med FDA´s godkendelse af Amgens (Micromet) godkendelse af Blincyto (blinatumomab), fik vi for alvor ..
27
18 dec
PNDORA
Nu har jeg købt og solgt aktier i 8 år og var os her på debatten for 4-5 år siden men har glemt mit ..
24
14 dec
VWS
Lomborg ved udmærket godt han er på gyngende grund, i mange af hans påstande.   Den værste er, når h..
17
18 dec
 
  Jeg er gratist, jeg læser med på EI uden at skrive. Det er sjældent, man kan få gratis lunch; men ..
13
14 dec
MAERSK-B
Husk nu at en produktions nedgang på små 500000 tønder om dagen kan få prisen til at stige markant m..
12
15 dec
GEN
Genmab har afholdt bestyrelsesmøde og valgt at give bestyrelse, direktion og ledende medarbejdere op..
11

Vestas vinder ordre på 34 MW i Tyrkiet - NY

19-12-2014 16:36:45
Vestas har fredag vundet en tyrkisk ordre på levering af 17 vindmøller med en samlet kapacitet på 34 megawatt.Det fremgår af en pressemeddelelse fra den danske ..

Novo Nordisk: Tresiba får positiv anbefaling om brug til børn

19-12-2014 13:26:58
En lægemiddelkomité under de europæiske sundhedsmyndigheder, EMA, anbefaler en udvidet indikation af diabetesmidlet Tresiba.Lægemiddelkomitéen, CHMP, anbefaler,..

Aktier/middag:Carlsberg presset i positivt C20

19-12-2014 11:42:20
Noget tyder på, at julestemningen har smittet af på investorerne på det danske aktiemarked. I hvert fald gør købelysten på det danske C20 Cap-indeks sig gældend..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. december 2014 03:36:18
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141211.1 - EUROWEB4 - 2014-12-21 03:36:18 - 2014-12-21 03:36:18 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x